Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity

[1]  M. Honda,et al.  Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma. , 2016, The Journal of infectious diseases.

[2]  Hong Tang,et al.  Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression. , 2016, Molecular pharmaceutics.

[3]  N. Enomoto,et al.  Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay , 2015, Marine drugs.

[4]  Haitao Guo,et al.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. , 2015, Antiviral research.

[5]  F. Zoulim,et al.  Antiviral therapies and prospects for a cure of chronic hepatitis B. , 2015, Cold Spring Harbor perspectives in medicine.

[6]  A. Lok,et al.  Hepatitis B virus infection , 2014, The Lancet.

[7]  Taesung Park,et al.  HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer , 2014, Gut.

[8]  T. Wakita,et al.  Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. , 2014, Biochemical and biophysical research communications.

[9]  G. Zang,et al.  Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells , 2014, Journal of viral hepatitis.

[10]  V. Teixeira,et al.  Dolabelladienols A–C, New Diterpenes Isolated from Brazilian Brown Alga Dictyota pfaffii , 2014, Marine drugs.

[11]  M. Menna,et al.  Meroterpenes from Marine Invertebrates: Structures, Occurrence, and Ecological Implications , 2013, Marine drugs.

[12]  N. Hayashi,et al.  Interferon-α suppresses hepatitis B virus enhancer II activity via the protein kinase C pathway. , 2012, Virology.

[13]  D. Hay,et al.  Edinburgh Research Explorer SUMOylation of HNF4 Regulates Protein Stability and Hepatocyte Function , 2012 .

[14]  H. Freeze,et al.  HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. , 2012, Chemistry & biology.

[15]  F. Zoulim,et al.  Selection of chronic hepatitis B therapy with high barrier to resistance. , 2012, The Lancet. Infectious diseases.

[16]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[17]  S. Tsuneda,et al.  Inhibition of hepatitis C virus NS3 helicase by manoalide. , 2012, Journal of natural products.

[18]  J. Schnabl,et al.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer , 2012, Proceedings of the National Academy of Sciences.

[19]  Y. Shaul,et al.  Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[20]  F. Zoulim.  Hepatitis B virus resistance to antiviral drugs: where are we going? , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[21]  U. Protzer,et al.  Control of hepatitis B virus at the level of transcription , 2010, Journal of viral hepatitis.

[22]  P. Proksch,et al.  Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance , 2010, Marine drugs.

[23]  F. Gonzalez,et al.  Developmental Regulation of Hepatitis B Virus Biosynthesis by Hepatocyte Nuclear Factor 4α , 2009, PloS one.

[24]  Y. Shaul,et al.  The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. , 2009, Biochemical and biophysical research communications.

[25]  J. Bar-Tana,et al.  Inhibition of colorectal cancer by targeting hepatocyte nuclear factor‐4α , 2009, International journal of cancer.

[26]  G. Muricy,et al.  Marine sponges: potential sources of new antimicrobial drugs. , 2009, Current pharmaceutical biotechnology.

[27]  Y. Kuo,et al.  The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters. , 2008, Antiviral research.

[28]  Y. Li,et al.  Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue , 2007, Proceedings of the National Academy of Sciences.

[29]  A. Cuconati,et al.  Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. , 2006, Antiviral research.

[30]  Y. Li,et al.  Inhibition of Hepatitis B Virus Gene Expression and Replication by Helioxanthin and its Derivative , 2005, Antiviral chemistry & chemotherapy.

[31]  A. Demain,et al.  Natural products : drug discovery and therapeutic medicine , 2005 .

[32]  Yu Hong,et al.  AMP-activated Protein Kinase Regulates HNF4α Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability* , 2003, Journal of Biological Chemistry.

[33]  J. Mertz,et al.  Distinct Modes of Regulation of Transcription of Hepatitis B Virus by the Nuclear Receptors HNF4α and COUP-TF1 , 2003, Journal of Virology.

[34]  A. Siddiqui,et al.  Interaction between STAT-3 and HNF-3 Leads to the Activation of Liver-Specific Hepatitis B Virus Enhancer 1 Function , 2002, Journal of Virology.

[35]  M. Classen,et al.  Different activities of type I interferons on hepatitis B virus core promoter regulated transcription. , 2002, Cytokine.

[36]  Hong Tang,et al.  Replication of the Wild Type and a Natural Hepatitis B Virus Nucleocapsid Promoter Variant Is Differentially Regulated by Nuclear Hormone Receptors in Cell Culture , 2001, Journal of Virology.

[37]  J. Ou,et al.  Differential Regulation of Hepatitis B Virus Gene Expression by the Sp1 Transcription Factor , 2001, Journal of Virology.

[38]  M. Manns,et al.  The Enhancer I Core Region Contributes to the Replication Level of Hepatitis B Virus In Vivo and In Vitro , 2000, Journal of Virology.

[39]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[40]  M. Kew,et al.  The core promoter of hepatitis B virus , 1999, Journal of viral hepatitis.

[41]  S. Malik,et al.  Control of Apolipoprotein AI Gene Expression through Synergistic Interactions between Hepatocyte Nuclear Factors 3 and 4* , 1996, The Journal of Biological Chemistry.

[42]  J. Lavine,et al.  Cytokine inhibition of the hepatitis B virus core promoter , 1996, Hepatology.

[43]  Johnm . Taylor,et al.  Structure of the Hepatic Control Region of the Human Apolipoprotein E/C-I Gene Locus (*) , 1995, The Journal of Biological Chemistry.

[44]  H. Schaller,et al.  Hepatitis B virus replication. , 2007, Trends in microbiology.

[45]  F. Sladek,et al.  Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. , 1993, The Journal of biological chemistry.

[46]  W. Müller,et al.  Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. , 1987, Journal of the National Cancer Institute.